AOTILSE:AOTI 21 EBITDA Margin % is 12.89% as of Dec. 2025, which is 185% above its 10-year median of 4.52. GuruFocus rates LSE:AOTI with a GF Score™ of 21/100. The stock has 8 warning signs investors should review. Among 816 Medical Devices & Instruments companies, AOTI ranks better than 58.33% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. AOTI's EBITDA for the
six
months ended in Dec. 2025 was £3.34 Mil. AOTI's Revenue for the
six
months ended in Dec. 2025 was £25.92 Mil. Therefore, AOTI's EBITDA margin for the quarter that ended in Dec. 2025 was 12.89%.
AOTI (LSE:AOTI) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
AOTI EBITDA Margin % Related Terms
AOTI EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for AOTI's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:AOTI vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, AOTI's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AOTI EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AOTI's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where AOTI's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AOTI (LSE:AOTI) has a EBITDA Margin % of 12.89% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on AOTI and its competitors. This is 185% above median its historical median of 4.52. According to the industry distribution chart, AOTI ranks #340 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 41.7%.
Is AOTI's EBITDA Margin % too high?
AOTI's current EBITDA Margin % of 12.89% is 185% above median its 10-year median of 4.52. The Medical Devices & Instruments industry median EBITDA Margin % is 7.39. AOTI's value of 12.89% is 74.5% above this industry median. Based on the distribution chart, AOTI ranks #340 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, AOTI has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does AOTI's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, AOTI ranks #340 out of 816 companies for EBITDA Margin %. This puts AOTI in the upper half of its industry. The industry median EBITDA Margin % is 7.39. AOTI's value of 12.89% is 74.5% above this benchmark. While the company's 10-year median is 4.52 vs. the industry median of 7.39, AOTI has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.39, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AOTI's current EBITDA Margin % of 12.89% is 74.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on AOTI and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AOTI's current EBITDA Margin % is 12.89%, which is 185% above median its own 10-year median of 4.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AOTI stock overvalued right now?
AOTI (LSE:AOTI) has a current EBITDA Margin % of 12.89%. The current EBITDA Margin % is 12.89%, which is 185% above median its 10-year median of 4.52 and 74.5% above the Medical Devices & Instruments industry median of 7.39. AOTI's overall GF Score™ is 21/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For AOTI (LSE:AOTI), the current EBITDA Margin % is 12.89% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AOTI Inc is the design, manufacture and provision of topical oxygen therapy products and services for healthcare providers and patients with chronic wounds. These products and services enable patients to heal faster and more durably and healthcare providers to reduce the overall cost of care. The specific purposes of the Company are to patent, manufacture, rent, and sell medical devices to help resolve severe acute and chronic wounds for customers globally. The Company operates in one reportable segment, which comprises the development and sale of Creative medical devices for therapeutic care. The company's solutions includes Multi-Modality Oxygen Therapy, Extremity Chamber, Multi-Patch, Negative Pressure Wound Therapy.
21GF Score
Get the complete analysis for LSE:AOTI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:AOTI has been successfully added to your 